BRCA携带者与非携带者胰腺变异性探索:扩散张量MRI研究
回顾性分析18例PDAC易感突变高危个体与17例对照的胰腺DT-MRI,发现λ1、λ2、λ3、ADC及FA在两对b值间差异显著(p<0.00001),但校正后上述指标及λ1、λ2、λ3比值在高危组与对照组间无显著差异;λ1、λ2、λ3比值显示IVIM相关方向性变化,提示胰腺毛细血管灌注存在方向差异。
要点
- DT-MRI可有效测量胰腺扩散系数及IVIM贡献。
- 校正后高危突变携带者与对照组间DTI指标无显著差异。
- λ1、λ2、λ3比值呈现IVIM相关方向性变化,提示毛细血管灌注方向差异。
核心结论
- DT-MRI能有效测量胰腺扩散系数和IVIM贡献;高危个体与对照组间无显著差异,因此该方法支持作为未来胰腺癌筛查研究的辅助、无偏倚工具。
研究设计与样本
- 回顾性数据分析,纳入18例携带PDAC易感突变的高危个体和17例接受常规胰腺MRI的对照,共35例;使用3T扫描仪,DT-MRI b值为0-500和100-500 s/mm²;收集临床、人口学和病理学数据;统计采用Wilcoxon符号秩检验、Mann-Whitney U检验和Benjamini-Hochberg校正。
诊断标准与关键数值
- DTI指标(λ1、λ2、λ3、表观扩散系数和分数各向异性)在两对b值间差异显著(p<0.00001);校正后上述指标及λ1、λ2、λ3比值(中位数分别为1.1、1.4、2.4,四分位距分别为0.11、0.22、0.76)在高危组与对照组间无显著差异。
临床应用与阅片要点
- 作者认为DT-MRI可有效测量胰腺扩散系数和IVIM贡献,并支持其作为未来胰腺癌筛查研究的辅助、无偏倚工具;校正后高危突变携带者与对照组间DTI指标无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease, often diagnosed at advanced, unresectable stages. Early detection is critical to improve survival, but current imaging modalities are limited in detecting early stage malignancies. Diffusion tensor MRI (DT-MRI) has shown potential in identifying PDAC. This study confirms the feasibility of DT-MRI to measure pancreatic diffusion metrics and examines whether DT-MRI detects any differences in these metrics between high-risk genetic mutations carriers and controls.
MATERIALS & METHODS: Retrospective data analysis included 18 high-risk individuals with PDAC-predisposing mutations and 17 controls undergoing routine pancreatic MRI. Participants underwent standard MRI and DT-MRI (3T scanner, b-values 0-500 and 100-500 s/mm2), with clinical, demographic, and pathological data collected. Statistical analyses included Wilcoxon signed-rank tests, Mann-Whitney U-tests, and Benjamini-Hochberg corrections.
RESULTS: Among 35 participants (14 males, 21 females), the median ages were 51 for high-risk and 65 for controls (p = 0.0436, Welch's t-test). DTI metrics (λ1, λ2 and λ3, apparent diffusion coefficient and fractional anisotropy) varied significantly between the two b-value pairs (p < 0.00001). However, these metrics and the λ1, λ2 and λ3 ratios (medians 1.1, 1.4, 2.4, IQRs 0.11, 0.22, 0.76, respectively) showed no significant differences between the high-risk and control groups after correction. Yet, λ1, λ2 and λ3 ratios showed IVIM-related directional variations, suggesting directional differences in capillary perfusion of the pancreas.
CONCLUSION: DT-MRI effectively measures diffusion coefficients and IVIM contributions in the pancreas. No significant differences were found between high-risk individuals and controls, therefore, the method supports adjunct, bias-free use in future pancreatic cancer screening studies.
引用
- Raitses-Gurevich M, Tau N, Moss Massasa EE, et al. Exploring pancreatic variability in BRCA carriers vs. Non-Carriers: A diffusion tensor MRI study. Eur J Radiol. 2025. PMID: 41151434. doi:10.1016/j.ejrad.2025.112483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。